Activation of Nrf2 Is Required for Normal and ChREBPα-Augmented Glucose-Stimulated β-Cell Proliferation

Patients with both major forms of diabetes would benefit from therapies that increase β-cell mass. Glucose, a natural mitogen, drives adaptive expansion of β-cell mass by promoting β-cell proliferation. We previously demonstrated that a carbohydrate response element–binding protein (ChREBPα) is requ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes
Autors principals: Kumar, Anil, Katz, Liora S., Schulz, Anna M., Kim, Misung, Honig, Lee B., Li, Lucy, Davenport, Bennett, Homann, Dirk, Garcia-Ocaña, Adolfo, Herman, Mark A., Haynes, Cole M., Chipuk, Jerry E., Scott, Donald K.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2018
Matèries:
Islet Studies
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6054434/
https://ncbi.nlm.nih.gov/pubmed/29764859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db17-0943
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars